Dr. Jasnit Makkar, M.D
NPI: 1811213358
Total Payments
$15,870
2024 Payments
$774.44
Companies
8
Transactions
15
Medicare Patients
12,506
Medicare Billing
$459,575
Payment Breakdown by Category
Consulting$14,563 (91.8%)
Food & Beverage$859.59 (5.4%)
Research$447.50 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,563 | 8 | 91.8% |
| Food and Beverage | $859.59 | 6 | 5.4% |
| Unspecified | $447.50 | 1 | 2.8% |
Payments by Type
General
$15,422
14 transactions
Research
$447.50
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Siemens Medical Solutions USA, Inc. | $4,340 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $3,773 | 4 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $3,750 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $2,700 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $691.55 | 3 | $0 (2024) |
| ABBVIE INC. | $250.00 | 2 | $0 (2024) |
| FUJIFILM Healthcare Americas Corporation | $201.94 | 1 | $0 (2024) |
| Boston Scientific Corporation | $163.60 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $774.44 | 3 | E.R. Squibb & Sons, L.L.C. ($447.50) |
| 2023 | $2,989 | 3 | Otsuka America Pharmaceutical, Inc. ($2,700) |
| 2022 | $5,750 | 2 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($3,750) |
| 2021 | $6,113 | 5 | Merck Sharp & Dohme Corporation ($3,773) |
| 2019 | $119.05 | 1 | E.R. Squibb & Sons, L.L.C. ($119.05) |
| 2018 | $125.00 | 1 | E.R. Squibb & Sons, L.L.C. ($125.00) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | — | Cash or cash equivalent | $447.50 | Research |
| Study: PhII Nivo vs. Nivo+Rela IO nave 2L+ HCC - A Phase 2, Randomized, Open-label Study of Relatlimab in Combination with Nivolumab in Participants with Advanced Hepatocellular Carcinoma who are Naive to IO Therapy but Progressed on Tyrosine Kinase Inhibitors • Category: Oncology | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | FUJIFILM Healthcare Americas Corporation | SYNAPSE 3D (Device) | Food and Beverage | In-kind items and services | $201.94 | General |
| Category: Medical Device | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: NEPHROLOGY | ||||||
| 03/31/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $163.60 | General |
| Category: General - Therapies_IC | ||||||
| 09/07/2022 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| 05/04/2022 | Siemens Medical Solutions USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 12/07/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $1,290.00 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $175.00 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2021 | Siemens Medical Solutions USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,340.00 | General |
| 07/20/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $87.50 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $119.05 | General |
| Category: Oncology | ||||||
| 01/16/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PhII Nivo vs. Nivo+Rela IO nave 2L+ HCC - A Phase 2, Randomized, Open-label Study of Relatlimab in Combination with Nivolumab in Participants with Advanced Hepatocellular Carcinoma who are Naive to IO Therapy but Progressed on Tyrosine Kinase Inhibitors | E.R. Squibb & Sons, L.L.C. | $447.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,309 | 9,649 | $1.0M | $109,454 |
| 2022 | 29 | 3,122 | 8,946 | $985,258 | $111,774 |
| 2021 | 30 | 2,945 | 7,811 | $895,441 | $120,516 |
| 2020 | 25 | 3,130 | 10,766 | $882,540 | $117,832 |
Total Patients
12,506
Total Services
37,172
Medicare Billing
$459,575
Procedure Codes
152
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 3 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2022 | 84 | 86 | $22,360 | $2,714 | 12.1% |
| 71260 | Ct scan of chest with contrast | Office | 2022 | 22 | 24 | $27,483 | $2,632 | 9.6% |
| 72197 | Mri scan of pelvis before and after contrast | Facility | 2022 | 22 | 22 | $13,200 | $2,094 | 15.9% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Facility | 2022 | 24 | 24 | $11,280 | $2,047 | 18.1% |
| 74018 | X-ray of abdomen, 1 view | Facility | 2022 | 208 | 257 | $12,850 | $2,028 | 15.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2022 | 11 | 11 | $18,330 | $1,963 | 10.7% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 17 | 17 | $18,570 | $1,959 | 10.6% |
| 76700 | Complete ultrasound scan of abdomen | Facility | 2022 | 54 | 54 | $20,520 | $1,893 | 9.2% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2022 | 91 | 94 | $14,885 | $1,806 | 12.1% |
| 76705 | Limited ultrasound scan of abdomen | Facility | 2022 | 63 | 67 | $18,760 | $1,724 | 9.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2022 | 41 | 41 | $10,660 | $1,465 | 13.7% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Facility | 2022 | 15 | 15 | $7,350 | $1,369 | 18.6% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Facility | 2022 | 21 | 22 | $9,020 | $1,071 | 11.9% |
| 76776 | Ultrasound scan of transplanted kidney | Facility | 2022 | 28 | 29 | $10,440 | $929.95 | 8.9% |
| 74230 | Imaging for evaluation of swallowing function | Facility | 2022 | 34 | 35 | $4,200 | $785.74 | 18.7% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2022 | 33 | 2,686 | $26,860 | $715.00 | 2.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 22 | 22 | $12,910 | $693.85 | 5.4% |
| 74220 | Single contrast x-ray of esophagus | Facility | 2022 | 26 | 26 | $2,860 | $603.26 | 21.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Facility | 2022 | 18 | 18 | $4,860 | $462.38 | 9.5% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Facility | 2022 | 20 | 20 | $3,000 | $434.43 | 14.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2022 | 11 | 11 | $2,640 | $394.93 | 15.0% |
| 74221 | Double contrast x-ray of esophagus | Facility | 2022 | 12 | 12 | $2,400 | $368.57 | 15.4% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2022 | 45 | 2,425 | $24,250 | $217.72 | 0.9% |
| 74019 | X-ray of abdomen, 2 views | Facility | 2022 | 20 | 21 | $1,260 | $193.67 | 15.4% |
| 73502 | X-ray of hip, 2-3 views | Facility | 2022 | 11 | 11 | $550.00 | $89.49 | 16.3% |
About Dr. Jasnit Makkar, M.D
Dr. Jasnit Makkar, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1811213358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jasnit Makkar, M.D has received a total of $15,870 in payments from pharmaceutical and medical device companies, with $774.44 received in 2024. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($14,563).
As a Medicare-enrolled provider, Makkar has provided services to 12,506 Medicare beneficiaries, totaling 37,172 services with total Medicare billing of $459,575. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Diagnostic Radiology
- Location Valhalla, NY
- Active Since 04/08/2010
- Last Updated 09/28/2015
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811213358
Products in Payments
- KEYTRUDA (Biological) $3,773
- JYNARQUE (Drug) $2,700
- OPDUALAG (Drug) $447.50
- VRAYLAR (Drug) $250.00
- OPDIVO (Biological) $244.05
- SYNAPSE 3D (Device) $201.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Valhalla
Eitan Glucksman, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,301
Student in an Organized Health Care Education/Training Program $30,301
Dr. Tasleem Katchi, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $7,795
Student in an Organized Health Care Education/Training Program $7,795
Dr. Logan Carr, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,431
Student in an Organized Health Care Education/Training Program $6,431
Dr. Gabriel Froula, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $4,560
Student in an Organized Health Care Education/Training Program $4,560
Dr. Ethan Paulin, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,429
Student in an Organized Health Care Education/Training Program $4,429
Jordan Stumph, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,842
Student in an Organized Health Care Education/Training Program $3,842